226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
10.49%
Net income growth similar to JD's 10.51%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
7.69%
D&A growth of 7.69% while JD is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
47.37%
Deferred tax of 47.37% while JD is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
35.19%
SBC growth of 35.19% while JD is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
126.90%
Working capital change of 126.90% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-117.99%
AR is negative yoy while JD is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-123.65%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
111.57%
AP growth of 111.57% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
423.91%
Growth of 423.91% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-18.25%
Both negative yoy, with JD at -301.39%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
153.80%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
-13.11%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
87.61%
Acquisition growth of 87.61% while JD is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
3.40%
Purchases growth of 3.40% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-33.21%
We reduce yoy sales while JD is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-100.00%
We reduce yoy other investing while JD is 248.67%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
42.88%
Lower net investing outflow yoy vs. JD's 230.06%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-38.46%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
200.00%
Issuance growth of 200.00% while JD is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.